cognitive cybersecurity intelligence

News and Analysis

Search

DEA and HHS extend virtual prescribing for controlled substances through 2025

The DEA and HHS announced a third temporary extension of COVID-19 telemedicine flexibilities for prescribing controlled medications, preventing patient medication access issues until December 31, 2025. The agencies are developing final rules for virtual prescribing to ensure public health and safety while addressing concerns over access barriers post-pandemic. They continue to consider feedback from stakeholders.

Source: www.healthcareitnews.com –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts